Get the latest market trends in your inbox

Stay on top of the latest market trends and economic insights with the Axios Markets newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Seema Verma, President Trump's nominee to lead the Centers for Medicare and Medicaid Services, is testifying before the Senate Finance Committee at her confirmation hearing this morning. So far, she has dodged a question about the new Obamacare rule, but made it clear she wants more flexibility in the benefits health insurers have to cover. She also suggested she'll be an ally for pharmacy benefit managers, the middlemen who are increasingly getting blamed for having a role in rising drug prices.

Read on for the highlights of what she said.

  • Said she couldn't comment on the new Obamacare regulation CMS released yesterday to tighten the enrollment rules: "I have not been involved in the development of that rule."
  • Democrats said the rule goes against President Trump's commitment to everyone having coverage, to which Verma replied with the standard GOP line: "The president and I both agree we need...to fight for coverage and make sure all Americans have access to affordable, high-quality health care."
  • She doesn't support turning Medicare into a "voucher program," as described by Sen. Bill Nelson (meaning GOP proposals to give private plans a bigger role). "I'm not supportive of that, but I think it's important we look for ways of making sure the program is sustainable for the future."
  • She supports changing Medicaid to make it work better, "whether that's a block grant or a per capita cap."
  • When asked whether Medicare should negotiate drug prices, she gave a shout-out to the increasingly villainized pharmacy benefit managers. "I think we need to do everything we can do to make drugs more affordable for seniors. I'm thankful we have the PBMs and Part D program."
  • On Obamacare's essential health benefits: "What works for one person might not work for another person." For example, some women might not want maternity coverage, she said. "I think it's important people be able to make the decisions that work best for them and their families."
  • Unsurprisingly, she praised Indiana's Medicaid system that she helped design, which uses health savings accounts in Medicaid. "What we find is just because individuals are poor doesn't mean they're not capable of making decisions."
  • She'll be recusing herself of any possible conflicts of interest. The AP reports she's promised to sell her consulting firm, which worked on the design of Indiana's Medicaid reform plan, within 90 days of being confirmed.
  • Called the 2015 MACRA bill, which reformed how Medicare pays doctors, an "important step forward" for outcomes and providers.

Go deeper

Dan Primack, author of Pro Rata
2 hours ago - Technology

TikTok gets more time (again)

Illustration: Aïda Amer/Axios

The White House is again giving TikTok's Chinese parent company more to satisfy national security concerns, rather than initiating legal action, a source familiar with the situation tells Axios.

The state of play: China's ByteDance had until Friday to resolve issues raised by the Committee on Foreign Investment in the U.S. (CFIUS), which is chaired by Treasury secretary Steve Mnuchin. This was the company's third deadline, with CFIUS having provided two earlier extensions.

Federal judge orders Trump administration to restore DACA

DACA recipients and their supporters rally outside the U.S. Supreme Court on June 18. Photo: Drew Angerer via Getty

A federal judge on Friday ordered the Trump administration to fully restore the Deferred Action for Childhood Arrivals program, giving undocumented immigrants who arrived in the U.S. as children a chance to petition for protection from deportation.

Why it matters: DACA was implemented under former President Obama, but President Trump has sought to undo the program since taking office. Friday’s ruling will require Department of Homeland Security officers to begin accepting applications starting Monday and guarantee that work permits are valid for two years.

Updated 4 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Politics: Fauci says he accepted Biden's offer to be chief medical adviser "on the spot" — The recovery needs rocket fuel.
  2. Health: CDC: It's time for "universal face mask use" — Death rates rising across the country — Study: Increased testing can reduce transmission.
  3. Economy: U.S. economy adds 245,000 jobs in November as recovery slows — America's hidden depression: K-shaped recovery threatens Biden administration.
  4. Cities: Bay Area counties to enact stay-at-home order ahead of state mandate
  5. Vaccine: What vaccine trials still need to do.
  6. World: UN warns "2021 is literally going to be catastrophic"
  7. 🎧 Podcast: Former FDA chief Rob Califf on the vaccine approval process.